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Edited by Maurice MontalAbstract Translationally controlled tumor protein (TCTP) has
both extra- and intracellular functions. Our group recently re-
ported that TCTP interacts with Na,K-ATPase and suppresses
its activity. Our studies led to the identiﬁcation of sorting nexin
6 (SNX6) which binds with TCTP as a potential negative regula-
tor of TCTP. SNX6 does not interact directly with any cytoplas-
mic domains of Na,K-ATPase. However, when overexpressed, it
restores the Na,K-ATPase activity suppressed by TCTP. This
was conﬁrmed by measurements of puriﬁed plasma membrane
Na,K-ATPase activity after incubation with recombinant TCTP
and SNX6. SNX6 alone has no eﬀect on Na,K-ATPase activity,
but activates Na,K-ATPase via inhibition of TCTP. Inhibition of
endogenous TCTP by the overexpression of SNX6 or knockdown
of TCTP expression by siTCTP increased Na,K-ATPase activity
above the basal level. The interaction between SNX6 and TCTP
thus appears to regulate Na,K-ATPase activity.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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protein; Sorting nexin 61. Introduction
Translationally controlled tumor protein (TCTP), also vari-
ously known as IgE-dependent histamine-releasing factor
(HRF), p23/p21, and fortilin, is distributed in all normal cell
types. It exhibits a high degree of homology among various
species, suggesting that TCTP may play an essential role in cel-
lular processes [1]. Many studies demonstrated that TCTP is a
multifunctional protein [2]. TCTP was reported to be involved,
extracellulaly in human allergic response as HRF [3], intracel-
lularly, as a microtubule-stabilizing protein [4], as an antiapo-
ptotic protein [5], and as a guanine nucleotide dissociation
inhibitor in protein synthesis [6]. Recently, TCTP has also been
reported as a suppressor of Na,K-ATPase by our group [7].Abbreviations: BAR, Bin-Amphiphysin-Rvs; CD, cytoplasmic domain;
EGFR, epidermal growth factor receptor; HRF, histamine-releasing
factor; IR, insulin receptor; PDGFR, platelet-derived growth factor
receptor; PX, phox; SNX, sorting nexin; TCTP, translationally cont-
rolled tumor protein; TFAF2, tumor necrosis factor receptor-associ-
ated factor 4 (TRAF4)-associated factor 2; TGF-bR, transforming
growth factor-b receptor
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doi:10.1016/j.febslet.2006.05.042Na,K-ATPase, sometimes called Na+ pump, is a multimem-
brane-spanning enzyme, and is essential for establishing and
maintaining high K+ and low Na+ in the cytoplasm, required
for various cellular activities such as regulation of cell volume,
maintenance of membrane potential, and nutrient transport.
This ionic homeostasis is critical for cell growth, diﬀerentia-
tion, and cell survival [8,9]. Na,K-ATPase is composed of a
catalytic a and a regulatory b subunit [10]. TCTP interacts
with the third large cytoplasmic domain (CD3) of a subunit
believed to be involved in the regulation of Na,K-ATPase
activity by protein kinases and hormones [7,11].
In the present study, we looked for TCTP-interacting pro-
teins that might regulate the activity of Na,K-ATPase. We
found that sorting nexin 6 (SNX6) inhibits the Na,K-ATP-
ase-suppressing activity of TCTP. SNX6, also named the
tumor necrosis factor receptor-associated factor 4 (TRAF4)-
associated factor 2 (TFAF2) [12], was originally isolated as
an interacting partner for Smad1 [13]. Later, this molecule
was found to bind with a variety of other receptors. These in-
clude: the receptor serine/threonine kinase TGF-bR, receptor
tyrosine kinases of EGFR, PDGFR, IR, and the long form
of the leptin receptors [14] such as other members of sorting
nexin family believed to function in intracellular traﬃcking
of target proteins [15]. SNX6 is widely expressed in multiple
tissues [14]. It is located in the cytoplasm and cell membrane
[16], and the nucleus after binding to Pim-1 [12]. However, lit-
tle is known of the cellular function of SNX6 other than that it
inhibits TGF-b signaling.2. Materials and methods
2.1. Yeast two-hybrid analysis
Yeast two-hybrid screening was performed as described previously
[17], using rat TCTP as bait and a mouse thymocyte cDNA library.
Protein–protein interaction results in activation of LexAop-Leu2 and
LexAop-LacZ reporter genes. Clones encoding TCTP-interacting
proteins were identiﬁed by DNA sequencing. One of these clones cor-
responded to SNX6. The cytoplasmic domains (CDs) of rat Na,
K-ATPase a1, a2 and b subunits were cloned into the LexA fusion
plasmid pEG202 as previously described [7]. Yeast cells were trans-
formed with both resulting in LexA fusion constructs and a SNX6
clone. The binding activity was evaluated by b-galactosidase activity
as reported previously [18], using the formula: b-galactosidase uni-
t = A420 · 1000/t (min) · volume of extract (ml) · protein (lg/ml).
2.2. Epitope-tagged constructs
Full-length human SNX6 cDNA was obtained from Dr. Jong-
Hoon Park (Sookmyung Women University, Seoul, Korea). Green
ﬂuorescence protein (GFP)-tagged SNX6 was generated by PCRblished by Elsevier B.V. All rights reserved.
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ampliﬁed fragments were digested with appropriate restriction en-
zymes and cloned into corresponding sites of mammalian expression
vector pEGFP-N1 (Clontech). His-tagged SNX6 was constructed in
bacterial expression vector pRSET (Invitrogen) for recombinant
SNX6 protein in same manner. HA-tagged TCTP, GFP-tagged
TCTP, and His-tagged TCTP constructs were from our previous
study [19].
2.3. Co-immunoprecipitation
HeLa cells were transiently tansfected with HA-TCTP construct
using LipofectAMINE PLUS (Invitrogen) or WelFect-EX PLUS
(WelGENE). After 24–48 h, the cells were lysed with an ice-cold ly-
sis buﬀer containing 50 mM Tris–HCl, pH 7.4, 150 mM NaCl,
1 mM EDTA, 1% Nonidet P-40, 0.25% sodium deoxycholate,
1 mM NaF, 1 mM Na3VO4, and Complete protease inhibitor
cocktail tablet (Roche Applied Science). After centrifugation, the
supernatants were mixed with mouse 12CA5 anti-HA monoclonal
antibody and incubated with protein G-agarose. The bound immune
complexes were pelleted and washed with ice-cold phosphate-buf-
fered saline (PBS, 136.9 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4,
1.5 mM KH2PO4, pH 7.4). The precipitated proteins were separated
on 12% SDS–polyacrylamide gel (SDS–PAGE). The blots obtained
were detected with mouse 12CA5 anti-HA monoclonal antibody,
mouse anti-Na,K-ATPase a1 monoclonal antibody and rabbit anti-
SNX6 polyclonal antibody (Zymed Laboratories Inc.). Same experi-
ments were done with untransfected HeLa cells. In this case, after
centrifugation of cell lysates, the supernatants were mixed with
mouse anti-Na,K-ATPase a1 monoclonal antibody (Upstate Bio-
technology) and blots were detected with mouse anti-Na,K-ATPase
a1 monoclonal antibody, rabbit anti-SNX6 polyclonal antibody
(Zymed Laboratories Inc.), and aﬃnity puriﬁed rabbit anti-TCTP
polyclonal antiserum raised from recombinant His-tagged TCTP in
our lab.
2.4. Knockdown of TCTP expression by small interfering RNA (siRNA)
siTCTP, construct for intracellular synthesis of TCTP siRNA was
made in pSUPER vector (OligoEngine). The functional siRNA corre-
sponding to 5 0-AGGTACCGAAAGCACAGTA-3 0 of human TCTP
gene was synthesized inside mammalian cells transfected with siTCTP
construct [20]. The level of suppression of TCTP gene was measured
from the amount of TCTP protein.
2.5. 86Rb+ uptake assay
HeLa cells were plated in 24-well plate at 5 · 104 cells/well and
were transfected with GFP, GFP-TCTP, GFP-SNX6, or siTCTP
constructs as mentioned above. After 24–48 h, the cells were incu-
bated for 3 h at 37 C in serum-free DMEM. The serum-starved cells
were washed with Krebs-Ringer phosphate buﬀer (KRP, 140 mM
NaCl, 5 mM KCl, 10 mM Na2HPO4, 1 mM MgSO4, 1.4 mM CaCl2,
and 2.5 mM glucose, 0.1% BSA, pH 7.4) and incubated with or with-
out 0.1 mM ouabain (a speciﬁc inhibitor of Na,K-ATPase) and/or
0.1 mM furosemide (an inhibitor of Na+,K+,2Cl cotransporter) in
the KRP for 15 min at 37 C. 86Rb+ was used as a tracer to measure
the uptake of K+. After incubation with 86Rb+ (1 lCi/ml) for 15 min
at 37 C, cellular 86Rb+ uptake was terminated by washing with ice-
chilled KRP and the cells were lysed with lysis buﬀer (50 mM NaOH,
1% Triton X-100) for 5 min. The radioactivity of the cell lysate from
one well was counted. The value obtained was adjusted for the
protein concentration.
2.6. Western blot analysis
Cells were prepared as described for the 86Rb+ uptake assay. The
proteins of total cell lysates were separated on 12% SDS–PAGE, blot-
ted, and incubated with anti-Na,K-ATPase a1 monoclonal antibody,
rabbit anti-GFP polyclonal antibody (Clontech), rabbit anti-TCTP
polyclonal antiserum.
2.7. In vitro Na,K-ATPase assay
The puriﬁed plasma membrane Na,K-ATPase fraction was obtained
from twenty 100-mm dishes of HeLa cells using the procedure de-
scribed in a previous report [21]. 0.04 mg/ml of plasma membrane
Na,K-ATPase fraction positioned at 30% sucrose was preincubatedwith various concentrations of ouabain (109–103 M), recombinant
TCTP (0.5–2 lg/ml), recombinant SNX6 (0.5–2 lg/ml), or a combina-
tion of recombinant TCTP and SNX6 of appropriate concentrations in
assay buﬀer (18 mM histidine, 18 mM imidazole, 80 mMNaCl, 15 mM
KCl, 3 mM MgCI2, and 0.1 mM EGTA, pH 7.4). The assay was then
started with the addition of ATP to a ﬁnal concentration of 5 mM.
After the incubation for 60 min at 37 C, the release of inorganic phos-
phate from ATP was quantiﬁed using the colorimetric method de-
scribed previously [22]. Recombinant TCTP and SNX6 were
produced by the bacterial expression pRSET vector system (Invitro-
gen) which contains the sequence for a His6 tag at the N-terminus of
the protein.2.8. Data analysis
Data are presented as the means ± S.E. Statistical analysis utilized
one-way analysis of variance (ANOVA) followed by post hoc Duncan
test.3. Results
3.1. TCTP interacts with both SNX6 and Na,K-ATPase
To better understand the functional role of TCTP in the reg-
ulation of Na,K-ATPase activity, we searched for TCTP-bind-
ing proteins using the yeast two-hybrid system. Using this
approach, we were able to isolate several cDNA clones. One
of these clones corresponded to the gene for SNX6 which en-
codes 406 amino acids (Fig. 1A). Fig. 1B, which shows the re-
sults of b-galactosidase activity assay, suggests that the
interaction between TCTP and SNX6 occurred inside the yeast
cell, and between TCTP and the third cytoplasmic domain of
Na,K-ATPase a1 subunit (a1CD3). We conﬁrmed that the
interactions of TCTP with both SNX6 and Na,K-ATPase oc-
cur in vivo by co-immunoprecipitation. After checking that
HeLa cells transfected with HA-TCTP construct expressed
23 kDa HA-TCTP, the immunoprecipitated complex prepared
with anti-HA antibody was blotted with anti-Na,K-ATPase a
subunit and anti-SNX6 antibody. HA-TCTP co-precipitated
both 100 kDa Na,K-ATPase a subunit and 50 kDa SNX6
(Fig. 1C). We also performed immunoprecipitation with
untrasfected HeLa cells to see if endogenous TCTP and
SNX6 are complexed with Na,K-ATPase. Immunoprecipita-
tion with anti-Na,K-ATPase antibody detected 50 kDa SNX6
and 23 kDa TCTP (Fig. 1D), suggesting that TCTP associates
with SNX6 as well as Na,K-ATPase, and their complex exists in
HeLa cells.3.2. SNX6 does not interact with Na,K-ATPase
To identify whether SNX6 itself interacts with the cytoplas-
mic domains of Na,K-ATPase like TCTP, individual Ura+-
His+Trp+ transformants were streaked onto Glc UraHis
TrpLeu and Gal UraHisTrpLeu plates and assayed
for b-galactosidase activity. No transformant of pEG202/cytol-
asmic domains of Na,K-ATPase subunits and pJG4–5/SNX6
activated the transcription of the respective reporter genes, sug-
gesting that the cytoplasmic domains of Na,K-ATPase a1, a2
and b subunits do not interact with SNX6 (Table 1). Although
the cytoplasmic domain of Na,K-ATPase b subunit showed a
slight increase in b-gal signal, it did not activate Leu2 reporter.
One cannot determine whether the N-terminal portion of
Na,K-ATPase a subunit interacts with SNX6 because the yeast
cells transformed with pEG202/a1NT or pEG202/a2NT always
activated reporter genes.
Fig. 1. TCTP interacts with both SNX6 and Na,K-ATPase. (A)
Schematic representation of SNX6. The PX domain is depicted by
shaded box and the BAR domain is black box. (B) b-Galactosidase
activity in yeast two-hybrid system. Yeast transformants harboring
pEG202/the third cytoplasmic domain of Na,K-ATPase a1 subunit
(a1CD3) and pJG4-5/TCTP, or pEG202/TCTP and pJG4-5/SNX6
were grown under galactose induction conditions, respectively. b-
galactosidase activity assay was performed to detect activation of
LexAop-LacZ reporter gene by protein–protein interaction. The
interaction between empty vector pEG202 and pJG4-5 is a negative
control, and the interaction of a1CD3 with clone 267 (coﬁlin) is a
positive control [17]. Values were converted to percentage of positive
control. Data are the average of four independent experiments ± S.E.
(C) Immunoprecipitation by HA-TCTP detects Na,K-ATPase and
SNX6. HeLa cells were transfected with HA-TCTP construct.
Immunoprecipitated complex was prepared from cell extracts
employing anti-HA antibody. The blot obtained from total cell
extract (20 lg) and immunoprecipitated complex was detected with
anti-Na,K-ATPase a subunit, anti-SNX6, and anti-HA. IP, immu-
noprecipitation. (D) Immunoprecipitation by Na,K-ATPase detects
SNX6 and TCTP. HeLa cell extracts were subjected to immunopre-
cipitation with anti-Na,K-ATPase antibody, followed by immuno-
blotting with anti-Na,K-ATPase a subunit, anti-SNX6, and anti-
TCTP. The whole cell extracts (5 lg) and the precipitates prepared in
the absence of anti-Na,K-ATPase antibody were examined as
controls.
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suppressed by overexpression of TCTP without change of
Na,K-ATPase protein level
To explore whether SNX6 is involved in the regulation of
Na,K-ATPase activity through interaction with TCTP, we
overexpressed SNX6 in HeLa cells and measured Na,K-
ATPase activity using 86Rb+ uptake assay. Because it has
been reported that 60% of 86Rb+ uptake in HeLa cells is ac-
counted for by Na,K-ATPase and another 30% by
Na+,K+,2Cl cotransporter, for a total of 90% [23], we deter-
mined the individual transporter activity using 0.1 mM oua-
bain (a speciﬁc inhibitor of Na,K-ATPase) and 0.1 mM
furosemide (an inhibitor of Na+,K+,2Cl cotransporter).
Fig. 2A shows that Na,K-ATPase activity of GFP-TCTP-
transfected cells was 14.5 ± 5.4% lower than that of mock.
This conﬁrms the previous report that overexpression of
TCTP inhibits Na,K-ATPase activity [7]. However, Na,K-
ATPase activity of cells co-transfected with both GFP-TCTP
and GFP-SNX6 recovered to the mock level and
Na+,K+,2Cl cotransporter and the residual transporter
activities were similar. These results suggest that the overex-
pression of SNX6 restores the Na,K-ATPase activity de-
creased by overexpression of TCTP. To clarify whether the
increase in Na,K-ATPase activity from overexpression of
SNX6 is caused by the change of Na,K-ATPase expression
level, Western blot of cells transfected as in the 86Rb+ uptake
assay was performed using anti-Na,K-ATPase a subunit
antibody. Fig. 2B demonstrates that the expression level of
a subunit was the same in all transfected cells. This suggests
that recovery of Na,K-ATPase activity in TCTP and SNX6-
co-transfected cells is not due to the increase of Na,K-ATP-
ase protein level. Although the expression level of SNX6 as
shown in Fig. 2B appeared to be much lower than that of
TCTP, SNX6 was able to restore the Na,K-ATPase activity
suppressed by overexpression of TCTP. This might be due to
diﬀerent cellular localization of the protein after transfection.
Indeed, subcellular fractionation analysis showed that 51–
28% of cellular SNX6 is localized in plasma membrane
(PM), whereas only 10–7% of cellular TCTP is localized in
plasma membrane (unpublished data). Thus, SNX6 localized
in PM seems to reverse the inhibition of Na,K-ATPase by
TCTP in PM.3.4. Recombinant SNX6 prevents recombinant TCTP from
suppressing puriﬁed plasma membrane Na,K-ATPase
activity in vitro
Using HeLa cell plasma membrane fraction enriched with
ouabain-sensitive Na,K-ATPase by removal of extraneous
protein, we investigated the eﬀect of SNX6 and TCTP on puri-
ﬁed membrane-bound Na,K-ATPase in vitro. Ouabain eﬀec-
tively decreased the activity of the puriﬁed plasma membrane
Na,K-ATPase used in this assay (IC50 = 2.85 · 107 M)
(Fig. 3A). Addition of recombinant TCTP to the puriﬁed
Na,K-ATPase resulted in a signiﬁcant decrease in its activity
in a dose-dependent manner (IC50 = 1.84 lg/ml) and ﬁnally
complete inhibition at 10 lg/ml above (data not shown) as pre-
viously reported [7]. However, this inhibition was prevented by
recombinant SNX6 (Fig. 3B). Moreover, although the recom-
binant SNX6 did not aﬀect Na,K-ATPase activity signiﬁ-
cantly, the puriﬁed Na,K-ATPase which existed ﬁrstly with
recombinant SNX6 was not inhibited by the addition of
Table 1
SNX6 does not interact with the cytoplasmic domains of Na,K-ATPase in yeast two-hybrid system
Na,K-ATPase subunit Construct Selective media plate b-Galactosidase activity (Unit)
pEG202
(DNA-binding)
pJG4-5 (transcription
activation)
Glc UHTL Gal UHTL Glc UHT Gal UHT
Control Negative – – 1 2
Positive – +++ 0 100
a1 NT (Met1-Cys93) SNX6 + + 38 37
CD2 (Glu151-Ile292) – – 1 1
CD3 (Lys354-Val759) – – 1 1
CD4 (Glu825-Arg848) – – 1 1
CT (Ile935-Tyr1023) – – 1 1
a2 NT (Met1-Cys91) SNX6 + + 35 34
CD2 (Glu149-Ile290) – – 1 1
CD3 (Lys352-Val756) – – 0 1
CD4 (Glu822-Arg845) – – 1 1
CT (Ile932-Tyr1020) – – 1 1
b CD (Ala1-Lys33) SNX6 – – 1 14
The CDs of the Na,K-ATPase a1, a2 and b subunits were fused to the LexA DNA-binding domain. SNX6 was fused to the B42 transcription
activation domain. Protein–protein interaction results in activation of LexAop-Leu2 and LexAop-LacZ reporter genes. The yeast cell transformed
with empty vector pEG202 and pJG4-5 was used as a negative control, and the yeast cell transformed with PEG202/a1CD3 and pJG4-5/267(coﬁlin)
as a positive control (25). b-Galactosidase activity values are the average of four independent determinations converted to percentage of positive
control. Gal, galactose; Glc, glucose; UHTL, without uracil, histidine, trptophan, leucine; NT, N-terminal portion; CD, cytoplasmic domain;
CT, C-terminal portion.
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speciﬁcally inhibits the ability of TCTP to suppress Na,K-
ATPase activity, which ultimately results in indirect activation
of Na,K-ATPase.
3.5. Overexpression of SNX6 activates Na,K-ATPase above the
basal level like knockdown expression of endogenous TCTP
We hypothesized that if the interaction between endogenous
SNX6 and TCTP is increased simultaneously, Na,K-ATPase
will be activated. To test this hypothesis, SNX6 alone was
overexpressed in HeLa cells and the individual transporter
activity was calculated by 86Rb+ uptake assay. As expected,
Na,K-ATPase activity of the GFP-SNX6-transfected cells
was 18.7 ± 4.2% higher than that of mock (Fig. 4A). Overex-
pression of SNX6 can promote the interaction between
SNX6 and endogenous TCTP, leading to upregulation of
Na,K-ATPase above the basal level via inhibition of Na,K-
ATPase-suppressive activity of endogenous TCTP. This sug-
gests that inhibition of Na,K-ATPase by endogenous TCTP
is a normal physiological event required for the maintenance
of cellular Na,K-ATPase activity to basal level under normal
environment. We made the siTCTP construct which markedly
downregulates the level of endogenous TCTP, and examined
whether the activation of Na,K-ATPase occurs in siTCTP-
transfected cells. As shown in Fig. 4A, siTCTP caused the acti-
vation of Na,K-ATPase as did the overexpression of SNX6,
suggesting Na,K-ATPase activity is usually inhibited to basal
level by endogenous TCTP. Additionally, Na,K-ATPase activ-
ity of cells, co-transfected with both siTCTP and GFP-SNX6,
was not diﬀerent from that of SNX6 or siTCTP alone. Fig. 4B
shows that Na,K-ATPase activation by overexpression of
SNX6 and decreased expression of TCTP was not caused by
increased expression of Na,K-ATPase. In siTCTP-transfected
cells, endogeneous TCTP expression was reduced by 70–80%.
Although siTCTP caused incomplete knockdown of TCTP,
co-transfection with both siTCTP and GFP-SNX6 still acti-vates Na,K-ATPase activity. As indicated before, this may
be, because, based on the subcellular fractionation analysis
of cellular TCTP (unpublished data), only 10–7% of the
remaining TCTP is probably localized in plasma membrane.
Thus the quantity of the remaining TCTP is probably insignif-
icant.4. Discussion
Because Na,K-ATPase is closely involved in physiological
and pathological phenomena, it is important to understand
the mechanisms that regulate its activity. We propose here that
Na,K-ATPase activity may be regulated by a complex mecha-
nism involving the interaction of TCTP with Na,K-ATPase
and SNX6. Our study suggests the existence of a tertiary com-
plex of Na,K-ATPase, TCTP, and SNX6 and that SNX6 acts
as the negative regulator of TCTP which was previously iden-
tiﬁed as a suppressor of Na,K-ATPase [7]. Furthermore, our
data demonstrate that the inhibition of Na,K-ATPase by
endogenous TCTP is a natural phenomenon existing for the
maintenance of cellular Na,K-ATPase activity at normal rest-
ing state and that Na,K-ATPase can be activated by inhibition
of endogenous TCTP via the interaction with SNX6. Although
siTCTP construct caused an incomplete knockdown of the
expression of endogenous TCTP (70–80%), this incomplete
knockdown had the same eﬀect on the activation of Na,K-
ATPase as overexpression of SNX6, implying the breakout
of normal resting Na,K-ATPase activity. It was recently re-
ported that knockdown of TCTP promotes apoptosis [24,25].
It appears that the ultimate role of endogenous TCTP is to
carry out critical functions for cell survival, although this needs
to be conﬁrmed by studying the eﬀect of knocking out the
TCTP gene.
It has been reported that TCTP and SNX6 are ubiquitously
expressed in multiple tissues and localized throughout the cell
Fig. 2. Overexpression of SNX6 recovers Na,K-ATPase activity which
is suppressed by overexpression of TCTP without change of Na,K-
ATPase protein level. (A) Individual transporter activity was measured
by 86Rb+ uptake assay. After HeLa cells were transfected with GFP
(mock) or GFP-TCTP, or co-transfected with GFP-TCTP and GFP-
SNX6 constructs, the cells were incubated with 0.1 mM ouabain and/
or 0.1 mM furosemide for 15 min at 37 C. 86Rb+ uptake by adding
1 lCi/ml 86Rb+ for 15 min was counted. Na,K-ATPase-dependent
86Rb+ uptake is deﬁned as the amount of 86Rb+ uptake in the presence
of furosemide that was inhibited by the addition of ouabain. Na+, K+,
2Cl cotransporter-dependent 86Rb+ uptake is deﬁned as the amount
of 86Rb+ uptake in the absence of inhibitors that was inhibited by the
addition of furosemide. Residual 86Rb+ uptake is deﬁned as 86Rb+
uptake that was not inhibited by either ouabain or furosemide. The bar
graph shows the results of three independent experiments ± S.E. One-
way ANOVA and post hoc Duncan test (*P < 0.05) were used to
establish the statistical signiﬁcance of Na,K-ATPase activity. (B) Eﬀect
of overexpression of TCTP and SNX6 on Na,K-ATPase protein
synthesis. After HeLa cells were transfected as same condition in (A),
the total cell extract (20 lg) was blotted with anti-Na,K-ATPase a
subunit and anti-GFP antibody.
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Fig. 3. Recombinant SNX6 inhibits recombinant TCTP which
suppresses the puriﬁed plasma membrane Na,K-ATPase activity
in vitro. (A) 0.04 mg/ml of the puriﬁed HeLa cell plasma membrane
Na,K-ATPase fraction was preincubated with various concentrations
of ouabain in assay buﬀer. Following incubation for 60 min at 37 C
with the addition of ATP (ﬁnal concentration 5 mM), the release of
inorganic phosphate from ATP was quantiﬁed using the Biotek FL-
600 plate reader at 630 nm for Na,K-ATPase acivity. (B) and (C) The
assay was performed with the combinations of recombinant TCTP and
SNX6 of indicated concentration as procedures described in (A).
Na,K-ATPase activity was measured by subtracting the amount of
inorganic phosphate of assay with recombinant protein alone from
that with Na,K-ATPase fraction plus recombinant protein. Data are
the average of three independent experiments ± S.E. Statistical signif-
icance of the results was established by one-way ANOVA and post hoc
Duncan test (*P < 0.005).
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sults from the later’s role as an inhibitor of TCTP, any imbal-
ance in the amounts of TCTP and SNX6, aﬀects their
interaction which in turn, aﬀects Na,K-ATPase activity.
SNX9, a member of sorting nexins, was found to be translo-
cated from cytosol to plasma membrane by insulin [26]. Inhi-
bition of TCTP by SNX6 may contribute to upregulation of
Na,K-ATPase by stimuli such as insulin. Studies are underway
to test this possibility. Moreover, the interaction of TCTP with
SNX6 may inﬂuence other functions of TCTP involved in
growth-related process, apoptosis and allergic response [2].
Currently, little is known of the cellular function of SNX6,
other than that SNX6 plays the role of interfering with
TGF-b signaling [14]. SNX6 is a member of sorting nexins, a
family of cytoplasmic and membrane-associated proteins. A
characteristic structural feature of the sorting nexins is thephox homology (PX) domain, a phosphoinositide-binding
module [27,28]. Because several sorting nexins with their PX
domains localize mainly in PtdIns(3)P-rich endosomal and
vacuolar, it has been suggested that they may function in the
endocytosis of plasma membrane and/or the traﬃcking of
Fig. 4. Overexpression of SNX6 activates Na,K-ATPase above the
basal level like knockdown expression of endogenous TCTP. (A)
Individual transporter activity was measured by 86Rb+ uptake assay.
HeLa cells were transfected with mock, GFP-SNX6, or siTCTP, or
co-transfected with siTCTP and GFP-SNX6 constructs. The exper-
imental procedures for 86Rb+ uptake assay were performed as
described in the legend of Fig. 2A. The deﬁnition of individual
transporter activity was described in the legend of Fig. 2A. The bar
graph shows the results of three independent experiments ± S.E.
Statistical signiﬁcance of Na,K-ATPase activity was established by
one-way ANOVA and post hoc Duncan test (*P < 0.0005). (B) Eﬀect
of SNX6 and knockdown of endogenous TCTP on Na,K-ATPase
and TCTP protein synthesis. After HeLa cells were transfected as
same condition in (A), the total cell extract (20 lg) was blotted with
anti-Na,K-ATPase a subunit, anti-GFP, anti-TCTP.
T. Yoon et al. / FEBS Letters 580 (2006) 3558–3564 3563proteins from one membrane compartment to another [29]. It
has been suggested that for some sorting nexins, membrane
association also requires their C-terminal coiled-coil regions
(BAR domain) as well as PX domain [16]. Several sorting nex-
ins including SNX6 consist of PX domain and a BAR domain
[30]. They homo- and hetero-oligomerize and colocalize intra-
cellularly through these domains [31]. Recently, the Bin/
Amphiphysin/Rvs (BAR) domain has been described as a
dimerization and membrane binding module which can sense
membrane curvature [32]. Moreover, this domain has the po-
tential to function as a small G-protein binding module
[32,33]. Thus, it is tempting to speculate that the sorting nexins
that share PX and BAR domains may share common func-
tions in the cell. However, the fact that individual sorting nex-
ins have diﬀerent speciﬁcities for interacting with the target
protein [15] implies that they may serve to select the speciﬁc
target protein to be conveyed within the particular transport
vesicles, or regulate the speciﬁc cellular functions unrelated
to their normal functions. Our demonstration that SNX6 is in-
volved in cellular ionic homeostasis via inhibition of TCTP
may be an example of such new functions.
Further studies are needed to understand the detailed mech-
anisms underlying the role of SNX6 as a TCTP-inhibitory pro-
tein. Elucidation of how Na,K-ATPase activation by SNX6
occurs may lead to more comprehensive approaches to TCTPregulation and the identiﬁcation of therapeutic targets to dis-
eases involving Na,K-ATPase, such as hypertension.
In conclusion, we identiﬁed SNX6 as a TCTP-binding pro-
tein and demonstrated that the interaction of TCTP with
SNX6 interferes with suppression of Na,K-ATPase by TCTP.
SNX6 therefore may be a key molecule serving as the negative
regulator of TCTP in the regulation of Na,K-ATPase activity
under physiological stimuli. Our demonstration of the indirect
regulation of Na,K-ATPase activity by SNX6 suggests a novel
molecular mechanism for the functional coupling of SNX6 and
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